Clinical development, registration, and introduction of human rotavirus vaccine: The Latin American experience

In Latin America rotavirus causes an estimated 15,000 deaths annually and accounts for 20–70% of acute gastroenteritis cases requiring hospitalization. This results in an estimated annual cost of approximately US$86 million. Continuous and expanding post-licensure rotavirus surveillance studies are needed to better assess the Read More …

Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review

An article presenting research and discussing regarding the burden of rotavirus in Western Europe was co-authored by Carlo Giaquinto and published in  BMC Infectious Diseases. The article concludes: This review confirms that RVGE is a common disease associated with significant morbidity and costs across Western Read More …

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality

Rotavirus vaccines have had a dramatic impact on morbidity and mortality from diarrhea among children in high- and middle-income countries that have introduced the vaccine into their national immunization programs. Widespread introduction of rotavirus vaccine in developing countries is imminent and their full Read More …